Literature DB >> 21545521

Melatonin attenuates brain contusion-induced oxidative insult, inactivation of signal transducers and activators of transcription 1, and upregulation of suppressor of cytokine signaling-3 in rats.

Ming Che Tsai1, Wei Ju Chen, Ming Shi Tsai, Cheng Hsin Ching, Jih Ing Chuang.   

Abstract

The induction of oxidative stress and inflammation has been closely linked in traumatic brain injury (TBI). Transcriptional factors of signal transducers and activators of transcription (STAT) proteins are redox sensitive and participate in the regulation of cytokine signaling. Previous studies demonstrated that melatonin protects neurons through its antioxidative and anti-inflammatory effects in various neuropathological conditions. However, the effect of melatonin on STAT activity after TBI has not yet been explored. In this study, we used a controlled weight-drop TBI model and found that brain contusion induced oxidative stress (a decreased level of total glutathione and an increased ratio of oxidized glutathione to total glutathione), a reduction in STAT1 DNA-binding activity, and consequently neuronal loss in a contusion depth-dependent manner. A significant increased mRNA expression of suppressor of cytokine signaling (SOCS3), inducible nitric oxide synthetase (iNOS), and interleukine-6 (IL-6), but a decreased protein expression of protein inhibitor of activated STAT (PIAS1), was found 24 hr after brain contusion. SOCS3 and PIAS1 are endogenous negative regulators of STAT1. Moreover, the combination of intraperitoneal and local (presoaked in gelfoam and placed on the traumatic cortex) administration of melatonin had the most pronounced influence in inhibiting all effects except the PIAS1 downregulation induced by brain contusion. The results suggest that SOCS-3 upregulation and oxidative stress may contribute to the STAT1 inactivation after TBI. Melatonin protects neurons from TBI by reducing oxidative stress, STAT1 inactivation, and upregulation of SOCS-3 and pro-inflammatory cytokines.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21545521     DOI: 10.1111/j.1600-079X.2011.00885.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  23 in total

Review 1.  Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.

Authors:  Seithikurippu R Pandi-Perumal; Ahmed S BaHammam; Gregory M Brown; D Warren Spence; Vijay K Bharti; Charanjit Kaur; Rüdiger Hardeland; Daniel P Cardinali
Journal:  Neurotox Res       Date:  2012-06-28       Impact factor: 3.911

Review 2.  Neuroprotective Mechanisms of Melatonin in Hemorrhagic Stroke.

Authors:  Hai-Jian Wu; Cheng Wu; Huan-Jiang Niu; Kun Wang; Lian-Jie Mo; An-Wen Shao; Brandon J Dixon; Jian-Min Zhang; Shu-Xu Yang; Yi-Rong Wang
Journal:  Cell Mol Neurobiol       Date:  2017-01-28       Impact factor: 5.046

Review 3.  Targeting the NF-E2-Related Factor 2 Pathway: a Novel Strategy for Traumatic Brain Injury.

Authors:  Li Zhang; Handong Wang
Journal:  Mol Neurobiol       Date:  2017-02-21       Impact factor: 5.590

Review 4.  Role of JAK-STAT and PPAR-Gamma Signalling Modulators in the Prevention of Autism and Neurological Dysfunctions.

Authors:  Rishabh Khera; Sidharth Mehan; Sumit Kumar; Pranshul Sethi; Sonalika Bhalla; Aradhana Prajapati
Journal:  Mol Neurobiol       Date:  2022-04-18       Impact factor: 5.590

Review 5.  The role of JAK-STAT signaling within the CNS.

Authors:  Celine S Nicolas; Mascia Amici; Zuner A Bortolotto; Andrew Doherty; Zsolt Csaba; Assia Fafouri; Pascal Dournaud; Pierre Gressens; Graham L Collingridge; Stephane Peineau
Journal:  JAKSTAT       Date:  2013-01-01

Review 6.  Melatonin Therapy in Patients with Alzheimer's Disease.

Authors:  Daniel P Cardinali; Daniel E Vigo; Natividad Olivar; María F Vidal; Luis I Brusco
Journal:  Antioxidants (Basel)       Date:  2014-04-10

Review 7.  Melatonin: buffering the immune system.

Authors:  Antonio Carrillo-Vico; Patricia J Lardone; Nuria Alvarez-Sánchez; Ana Rodríguez-Rodríguez; Juan M Guerrero
Journal:  Int J Mol Sci       Date:  2013-04-22       Impact factor: 5.923

8.  Microglia activation as a biomarker for traumatic brain injury.

Authors:  Diana G Hernandez-Ontiveros; Naoki Tajiri; Sandra Acosta; Brian Giunta; Jun Tan; Cesar V Borlongan
Journal:  Front Neurol       Date:  2013-03-26       Impact factor: 4.003

9.  A double-blind, placebo-controlled intervention trial of 3 and 10 mg sublingual melatonin for post-concussion syndrome in youths (PLAYGAME): study protocol for a randomized controlled trial.

Authors:  Karen M Barlow; Brian L Brooks; Frank P MacMaster; Adam Kirton; Trevor Seeger; Michael Esser; Susan Crawford; Alberto Nettel-Aguirre; Roger Zemek; Mikrogianakis Angelo; Valerie Kirk; Carolyn A Emery; David Johnson; Michael D Hill; Jeff Buchhalter; Brenda Turley; Lawrence Richer; Robert Platt; Jamie Hutchison; Deborah Dewey
Journal:  Trials       Date:  2014-07-07       Impact factor: 2.279

10.  Melatonin treatment reduces astrogliosis and apoptosis in rats with traumatic brain injury.

Authors:  Abdolreza Babaee; Seyed Hassan Eftekhar-Vaghefi; Majid Asadi-Shekaari; Nader Shahrokhi; Samereh Dehghani Soltani; Reza Malekpour-Afshar; Mohsen Basiri
Journal:  Iran J Basic Med Sci       Date:  2015-09       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.